Phillips S J
Iowa Heart Center, Mercy Hospital Medical Center, Des Moines, IA.
Semin Thorac Cardiovasc Surg. 1994 Jul;6(3):131-5.
Between 1975 and 1993, 73 patients in cardiogenic shock were supported by a variety of venoarterial pumping (VAP) systems. There were 64 adults and 9 children. Shock was caused by myocardial infarction (MI) (26), failed percutaneous transluminal coronary angioplasty (PTCA) (25), post open heart surgery (9), viral cardiomyopathy (5), idiopathic cardiomyopathy (2), pulmonary embolism (2), hypothermia (2), and arrhythmia (2). Forty-three patients were treated with percutaneous bypass and 30 by surgical bypass. Resuscitated patients were usually bridged to further therapies such as coronary artery bypass graft (CABG), valve repair or replacement or cardiac transplantation. Overall, 35 patients (48%) survived VAP and additional therapies. We conclude that early application of complete cardiopulmonary support to patients in shock allows resuscitation and corrective therapy with an acceptable salvage rate.
1975年至1993年间，73例心源性休克患者接受了各种静脉-动脉泵（VAP）系统的支持治疗。其中有64名成人和9名儿童。休克的病因包括心肌梗死（MI）（26例）、经皮腔内冠状动脉成形术（PTCA）失败（25例）、心脏直视手术后（9例）、病毒性心肌病（5例）、特发性心肌病（2例）、肺栓塞（2例）、体温过低（2例）和心律失常（2例）。43例患者接受了经皮旁路治疗，30例接受了手术旁路治疗。复苏后的患者通常会过渡到进一步的治疗，如冠状动脉旁路移植术（CABG）、瓣膜修复或置换或心脏移植。总体而言，35例患者（48%）在接受VAP及其他治疗后存活。我们得出结论，对休克患者早期应用完全心肺支持可实现复苏和纠正治疗，且挽救率可接受。
